Clinical trial / 2022
A 10-mg/d vitamin C intake was associated with 42% weaker scar strength versus 80 mg/d in a reanalysis of historical trial data.
Researchers statistically analyzed published individual participant data on scar strength from a double-blind controlled trial initiated in 1944. An average vitamin C intake of 10 mg/d over a mean follow-up of 11.5 months was associated with a 42% weakened scar strength compared with 80 mg/d (P < 0.001). Additionally, with an average intake of 65 mg/d over a mean follow-up of 6.5 months, vitamin C-depleted tissues had a 49% weaker scar strength when compared with nondepleted tissues (P < 0.05). The authors report that the observed dose-response curve suggests the daily intake needed to prevent collagen-related pathologies is in the range of 75 to 110 mg/d rather than the WHO recommendation of 45 mg/d.
- Study type
- Statistical reanalysis of a 1944 double-blind controlled trial
- Who was studied
- Participants from a 1944 trial with published individual participant data
- What was measured
- Scar strength
THE PAPER
Vitamin C and scar strength: analysis of a historical trial and implications for collagen-related pathologies.
Hujoel PP, Hujoel MLA. Am J Clin Nutr, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.